Bluejay Diagnostics, Inc. BJDX shares are flying higher on Friday. The stock has been moving higher after the company announced a reverse stock split last Friday. Here's a look at what's going on.
What To Know:
Bluejay Diagnostics announced the approval of a 1-for-20 reverse stock split last Friday, and BJDX effected the reverse stock split on Monday. Shares of BJDX are up more than 20% since the reverse stock split and up over 40% for the session. Trading of BJDX was halted on Friday morning on a circuit breaker to the upside and has since resumed normal trading.
According to data from Benzinga Pro, more than 7 million shares of BDJX have been traded in the session, compared to the stock's 100-day average of just under 244,700 shares.
Bluejay Diagnostics, Inc. is a medical diagnostics company engaged in the development and manufacturing of clinical diagnostic products that improve the quality of medical diagnoses. The company's first product, the Symphony IL-6 test, monitors disease progression in critical care settings. The company is a provider of rapid tests for infectious, inflammatory, and metabolic diseases by the Symphony platform.
Related News: What's Going On With Tilray Shares?
BJDX Price Action: According to Benzinga Pro, shares of Bluejay Diagnostics are trading 41.5% higher at $7.57 at the time of publication.
Image: jarmoluk from Pixabay
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
